Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL27370011 | 0.98 | MAOA (0.35) | MAOAMAOBHTR2ACYP2D6MEN1 | |
| SCHEMBL15535721 | 0.76 | MAOA (0.39) | MAOAMAOBHTR2ACYP2D6MEN1 | |
| SCHEMBL8531996 | 0.74 | MAOA (0.38) | MAOAMAOBHTR2ACYP2D6MEN1 | |
| SCHEMBL30424597 | 0.74 | HTR2A (0.38) | HTR2AMEN1GAAKMT2AHTR6 | |
| SCHEMBL28742878 | 0.73 | MAOA (0.41) | MAOAMAOBHTR2ACYP2D6MEN1 | |
| SCHEMBL27428432 | 0.73 | MAOA (0.37) | MAOAMAOBHTR2ACYP2D6GAA | |
| SCHEMBL12629758 | 0.73 | MAOA (0.37) | MAOAMAOBHTR2ACYP2D6MEN1 | |
| SCHEMBL5574454 | 0.73 | DRD2 (0.40) | HTR2AHTR6 | |
| SCHEMBL27822069 | 0.73 | MAOA (0.37) | MAOAMAOBHTR2ACYP2D6MEN1 | |
| SCHEMBL27316211 | 0.73 | MAOA (0.37) | MAOAMAOBHTR2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113501843-B | Synthesis method of trivalent phosphorus substituted amine compound | 兰州大学 | 2023-06-02 | — | — | CN | claimed |
| CN-121318804-A | Method for preparing chiral sulfinate by asymmetric oxidation | 西安近代化学研究所 | 2026-01-13 | — | — | CN | disclosed |
| US-20250092312-A1 | ANTIPOLYMERANT COMPOSITIONS WITH BENZOQUINONE OR NAPHTHOQUINONE AND OXYGENATED AMINOPHENOL AND METHODS OF USING | ECOLAB USA INC. | 2025-03-20 | — | — | US | disclosed |
| WO-2025059441-A1 | ANTIPOLYMERANT COMPOSITIONS WITH BENZOQUINONE OR NAPHTHOQUINONE AND OXYGENATED AMINOPHENOL AND METHODS OF USING | ECOLAB USA INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| CN-117756746-A | Preparation method of cyclic sulfonamide compound | 上海工程技术大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-110267944-B | Compounds useful for the treatment of gastrointestinal disorders | 阿德利克斯股份有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-11866631-B2 | Oxygenated aminophenol compounds and methods for preventing monomer polymerization | ECOLAB USA INC. (US) | 2024-01-09 | — | — | US | disclosed |
| CN-113680386-B | N-heterocyclic carbene-squaraine difunctional catalyst and preparation method thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2023-08-11 | — | — | CN | disclosed |
| CN-113731488-B | N-heterocyclic carbene-urea difunctional catalyst and preparation method thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2023-08-04 | — | — | CN | disclosed |
| CN-113680385-B | N-heterocyclic carbene-thiourea bifunctional group catalyst and preparation method and application thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2023-05-23 | — | — | CN | disclosed |
| WO-2023023880-A1 | NITROGEN HETEROCYCLIC CARBENE-UREA BIFUNCTIONAL CATALYST AND PREPARATION METHOD THEREFOR | 深圳湾实验室坪山生物医药研发转化中心 | 2023-03-02 | — | — | WO | disclosed |
| CN-106674400-A | Ethylene copolymer having excellent processability | 韩华道达尔有限公司 | 2017-05-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11866631-B2 | Oxygenated aminophenol compounds and methods for preventing monomer polymerization | HPD, DNPEP, PAH | MAOA 46/4885MAOB 64/4885HTR2A 576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.